Chitooligosaccharide/Polydopamine Co-Deposition Modifying Substrates for High-Performance Forward Osmosis Membranes with Enhanced Antibacterial and Antifouling Properties.

Ming-Xiao Zhang, Rui Han, Zhen-Liang Xu, Xin Zhang, Dibakar Pandaya

Abstract read

In one paragraph

Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ming-Xiao ZhangState Key Laboratory of Chemical Engineering, Membrane Science and Engineering R&D Lab, Chemical Engineering Research Center, School of Chemical Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Rui HanState Key Laboratory of Chemical Engineering, Membrane Science and Engineering R&D Lab, Chemical Engineering Research Center, School of Chemical Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Zhen-Liang XuState Key Laboratory of Chemical Engineering, Membrane Science and Engineering R&D Lab, Chemical Engineering Research Center, School of Chemical Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.ORCID 0000-0002-1436-4927

Xin ZhangState Key Laboratory of Chemical Engineering, Membrane Science and Engineering R&D Lab, Chemical Engineering Research Center, School of Chemical Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Dibakar PandayaState Key Laboratory of Chemical Engineering, Membrane Science and Engineering R&D Lab, Chemical Engineering Research Center, School of Chemical Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Funding

National Key R&D Program of China 2021YFB3801103National Natural Science Foundation of China 22078092

6 · The paper itself

Abstract

Forward osmosis (FO) membranes have garnered widespread research interest in water treatment, yet their permeability-selectivity trade-off, internal concentration polarization, and membrane fouling remain critical challenges. Herein, a chitooligosaccharide/polydopamine (COS/PDA) co-deposition strategy was proposed to modify polyethersulfone (PES) substrates for constructing high-performance thin-film composite (TFC) FO membranes. COS suppressed excessive PDA aggregation, reduced substrate roughness, and improved substrate hydrophilicity. This substrate modification regulated interfacial polymerization by increasing the adsorption capacity for m-phenylenediamine (MPD) while slowing its diffusion rate, thereby forming thinner, smoother, and more densely crosslinked polyamide (PA) layers. The optimized C

Indexed as

antibacterialantifoulingchitooligosaccharideco-depositionforward osmosispolyamidepolydopamine

Identifiers

PMID42346942

DOI10.3390/membranes16060186

PMCPMC13302806

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.